Covestor’s iRadimed IRMD Stock Holding History

Covestor’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Sell	10 -8	-44%	-$800	﹤0.01%	2063
2025 Q4	$2K	Sell	18 -5	-22%	-$429	﹤0.01%	1924
2025 Q3	$2K	Sell	23 -1	-4%	-$67	﹤0.01%	1954
2025 Q2	$1K	Sell	24 -7	-23%	-$384	﹤0.01%	2019
2025 Q1	$2K	Sell	31 -18	-37%	-$1.01K	﹤0.01%	1851
2024 Q4	$3K	Buy	49 +28	+133%	+$1.47K	﹤0.01%	1804
2024 Q3	$1K	Sell	21 -8	-28%	-$369	﹤0.01%	2009
2024 Q2	$1K	Buy	29 +18	+164%	+$766	﹤0.01%	2026
2024 Q1	$1K	Buy	11 +2	+22%	+$88	﹤0.01%	2003
2023 Q4	$0	Buy	9 +1	+13%	+$42	﹤0.01%	2397
2023 Q3	$0	Sell	8 -1	-11%	-$46	﹤0.01%	2385
2023 Q2	$0	Buy	+9	New	+$406	﹤0.01%	2377
2022 Q4	–	Sell	-10	Closed	–	–	2312
2022 Q3	$0	Buy	+10	New	+$348	﹤0.01%	2275

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Covestor's IRMD Position: Q1 2026 in Review

Covestor reduced its iRadimed (IRMD) stake by 44% in Q1 2026, selling an estimated $800 and leaving 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Covestor first reported a position in IRMD in Q3 2022 and has held it in 13 quarters since. The position peaked at $3K in Q4 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Covestor held 10 shares of iRadimed worth $1K as of Q1 2026.
Covestor sold 8 iRadimed shares in Q1 2026, an estimated $800.
iRadimed made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2063 holding.
Covestor first reported a position in iRadimed in Q3 2022 and has held it in 13 quarters since.
Covestor's iRadimed position peaked at $3K in Q4 2024.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.